Key Takeaways
- • Benchmark initiated coverage on Rigetti Computing (NASDAQ: RGTI) with a Buy rating and $25.00 price target, implying 64% upside from the stock's $15.24 current price, though InvestingPro data flags fair value at $8.34, signaling a significant valuation disconnect.
- • Rigetti secured a letter of intent from the U.S. Department of Commerce for up to $100 million in CHIPS Act funding over three years to support superconducting quantum computing R&D, providing substantial capital backing for technology development.
- • Benchmark simultaneously restarted coverage of the quantum computing sector broadly with Buy ratings on three companies (Rigetti, IonQ, and D-Wave Quantum), reflecting a bullish thesis on sector maturation and the achievement of fault tolerance capabilities required for quantum advantage.
- • The firm advocates a portfolio diversification approach to early-stage quantum computing investments, rejecting a winner-takes-all framework and positioning multiple players as investable opportunities pre-quantum advantage realization.
- • Analyst price targets for Rigetti range from $20 to $40 despite the company generating only $10 million in revenue over the last twelve months against a $4.7 billion market capitalization, highlighting the speculative premium attached to quantum computing plays.
Summary
Benchmark analyst David Williams announced the initiation of coverage on Rigetti Computing with a Buy rating and $25.00 price target on July 27, 2026, signaling conviction in the quantum computing company's prospects. The target implies 64% upside from the stock's then-current trading level of $15.24. However, this valuation creates tension with InvestingPro's fair value estimate of $8.34 per share, suggesting potential overvaluation at analyst consensus levels. The disconnect underscores the high-conviction nature of quantum computing bets and the speculative positioning embedded in sector valuations.
Rigetti's revenue base remains nascent, generating only $10 million over the trailing twelve months against a market capitalization of $4.7 billion. This multiple reflects investor positioning for future commercialization of quantum computing capabilities rather than near-term financial performance. The company's recent signing of a letter of intent with the U.S. Department of Commerce for up to $100 million in CHIPS Act funding over three years provides meaningful capital support for superconducting quantum computing research and development, de-risking the technology pathway and signaling government backing for the sector.
Benchmark's broader thesis centers on the quantum computing sector's increasing legitimacy and maturing technical foundations. The firm released a detailed industry report titled "A Deep-Dive Primer - The Truths & Fiction in Quantum Compute" alongside its coverage reinstatement, positioning the sector beyond hype cycle phases. Specifically, Benchmark highlighted fault tolerance as a critical capability required to achieve universal quantum advantage for solving practical, real-world problems. The firm explicitly rejected a winner-takes-all investment narrative, instead recommending a portfolio approach to quantum computing equity exposure during the pre-commercialization phase.
This diversification strategy is evident in Benchmark's simultaneous Buy initiations on Rigetti, IonQ, and D-Wave Quantum, each with distinct price targets. The ratings distribution reflects conviction that multiple pathways and technology platforms merit investment before clear market dominance crystallizes. Analyst price targets on Rigetti range from $20 to $40, with the broader analyst community maintaining a moderate buy consensus. This positioning establishes Rigetti as a core quantum computing exposure for institutional investors adopting sector-level exposure strategies rather than single-company bets.
Rigetti's revenue base remains nascent, generating only $10 million over the trailing twelve months against a market capitalization of $4.7 billion. This multiple reflects investor positioning for future commercialization of quantum computing capabilities rather than near-term financial performance. The company's recent signing of a letter of intent with the U.S. Department of Commerce for up to $100 million in CHIPS Act funding over three years provides meaningful capital support for superconducting quantum computing research and development, de-risking the technology pathway and signaling government backing for the sector.
Benchmark's broader thesis centers on the quantum computing sector's increasing legitimacy and maturing technical foundations. The firm released a detailed industry report titled "A Deep-Dive Primer - The Truths & Fiction in Quantum Compute" alongside its coverage reinstatement, positioning the sector beyond hype cycle phases. Specifically, Benchmark highlighted fault tolerance as a critical capability required to achieve universal quantum advantage for solving practical, real-world problems. The firm explicitly rejected a winner-takes-all investment narrative, instead recommending a portfolio approach to quantum computing equity exposure during the pre-commercialization phase.
This diversification strategy is evident in Benchmark's simultaneous Buy initiations on Rigetti, IonQ, and D-Wave Quantum, each with distinct price targets. The ratings distribution reflects conviction that multiple pathways and technology platforms merit investment before clear market dominance crystallizes. Analyst price targets on Rigetti range from $20 to $40, with the broader analyst community maintaining a moderate buy consensus. This positioning establishes Rigetti as a core quantum computing exposure for institutional investors adopting sector-level exposure strategies rather than single-company bets.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.